THIS EVENT HAS PASSED. Click here to view recorded talks from this event.

OVERVIEW

Welcome to the 2024 Mellen Center Update in Multiple Sclerosis (MS). This is our 16th symposium and we are excited to introduce some structural changes this year. We will have our usual afternoon rehabilitation track, but instead of two other afternoon tracks, we will consolidate into one track with shorter, more impactful presentations. Our hope is that this will offer attendees more “bang for their buck” and help to reduce the “fear of missing out” that comes with choosing between multiple simultaneous talks.

I am thrilled to announce that Dr. John Corboy will be our keynote speaker. Dr. Corboy is Professor of Neurology at the University of Colorado and has had a distinguished career in the field of MS. In particular, Dr. Corboy has been a leader in addressing the question of when it is appropriate to discontinue disease-modifying therapies in MS patients. He was the lead investigator of the DISCOMS study, a multi-center randomized discontinuation trial, the results of which will be discussed. Additionally, Dr. Amy Kunchok will be discussing neurologic complications of immune checkpoint inhibitors, an effective new immunotherapy for cancer. Dr. Cohen will also be updating us on trending three letter acronyms in MS, giving us the latest on BTK (Bruton’s tyrosine kinase) inhibitors, NFL (neurofilament light chain), and EBV (Epstein-Barr virus).

Our afternoon rehabilitation track will include engaging talks on high-tech mobility devices for MS and the best approach to patients with an early diagnosis of MS. In our clinical/research track, a number of important topics will be discussed including the evidence behind extended interval dosing of natalizumab and the latest on pregnancy and breastfeeding in the MS patient. Dr. Justin Abbatemarco will be giving us an update on the criteria proposed by the International Myelin Oligodendrocyte Antibody Disease (MOGAD) Panel for the diagnosis of MOGAD. We’ll finish off the afternoon with a round-table discussion of how MS patients are using social media and how to address patient questions that arise from content seen online.

A number of other fascinating talks are also planned for this year’s symposium, which will be offered both in-person and virtually. We welcome you to join us for the Mellen Center Update and believe you will find the program stimulating and educational!

TARGET AUDENCE

LEARNING OBJECTIVES

After completing this activity, the participant will be able to do the following:

• Describe new updates in multiple sclerosis disease-modifying therapies including BTK inhibitors and extended interval dosing with natalizumab.
• Explain the results of the DISCO-MS study and current approaches to disease-modifying therapy discontinuation in multiple sclerosis patients.
• Describe the role of health-related quality of life in children with multiple sclerosis.
• Summarize the role of wellness and women’s health in management strategies for patients with multiple sclerosis.
• Critically appraise neurologic complications of immune checkpoint inhibitors.
• Explain updates in clinical research pertaining to multiple sclerosis and the proposed diagnostic criteria for myelin oligodendrocyte glycoprotein antibody disease.
• Describe the latest MS rehabilitation, including dry needling, mobility devices, and high-intensity aerobic exercise.

ACCREDITATION

In support of improving patient care, Cleveland Clinic Center for Continuing Education is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

CREDIT DESIGNATION

American Medical Association (AMA)
Cleveland Clinic Center for Continuing Education designates this live activity for a maximum of 6 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensu-rate with the extent of their participation in the live activity.

Participants claiming CME credit from this live activity may submit the credit hours to the American Osteopathic Association for Category 2 credit.

American Nurses Credentialing Center (ANCC)
Cleveland Clinic Center for Continuing Education designates this live activity for a maximum of 6 ANCC contact hours.

American Academy of PAs (AAPA)
Cleveland Clinic Center for Continuing Education has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in
accordance with AAPA CME Criteria. This activity is designated for 6 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.

Interprofessional Continuing Education (IPCE) Credit
This activity was planned by and for the healthcare team, and learners will receive 6 Interprofessional Continuing Education (IPCE) credit for learning and change.

Ohio Psychological Association (OPA)
OPA-MCE Provider – Approved for 6 credits.

Ohio Physical Therapy Association (OPTA)
The Ohio Physical Therapy Association (OPTA) has approved this symposium for 5.75 hours.

OT section of the Ohio OTPTAT Board
Credit is being applied for with the OT section of the Ohio OTPTAT Board – Approval is pending.

Speech Language-Pathology
This activity has been approved by the Ohio Speech and Hearing Professionals Board for 6 clock hours of continuing education for the 2023–2024 practice biennium.

Certificate of Participation
A certificate of participation will be provided to other health care professionals for requesting credits in accordance with their professional boards and/or associations.

For more information please visit the official event page.